The ARTEMISA project is set to revolutionize the diagnosis and treatment of complex cardiac arrhythmias, particularly atrial fibrillation and atypical flutters, by developing the first-ever integrated endo-epicardial cardiac mapping system. Current technologies are limited in their ability to provide a comprehensive, real-time view of electrical activity across the entire heart, leading to suboptimal treatment outcomes and significant healthcare costs.
ARTEMISA addresses this critical clinical need through a multidisciplinary approach, combining invasive catheter-based mapping with non-invasive electrocardiographic imaging (ECGI) to reconstruct electrical activity across the entire atrial muscle – from the epicardium to the endocardium and even the mesocardium. This innovative solution will enable precise identification of arrhythmogenic substrates, optimizing ablation therapies and significantly improving success rates.
The project brings together a consortium of leading experts and institutions, including Corify Care (project coordinator, a medical device start-up), Universitat Politècnica de València (UPV), Universidad Pública de Navarra (UPNA), Mondragon Components Competence Center (MC3), Embega (specialized in printed electronics), and the Hospital General Universitario Gregorio Marañón (clinical validation platform). Their collective expertise spans advanced cardiac mapping, intelligent sensor development, innovative materials, and industrial manufacturing.
Key innovations include advanced volumetric reconstruction algorithms that integrate diverse data, intelligent and adaptive sensors for automatic real-time localization, and scalable manufacturing processes utilizing novel conductive gels and inks. ARTEMISA is poised to set a new standard in electrophysiology, offering unparalleled precision, accessibility, and clinical efficiency, ultimately enhancing patient quality of life and reducing the burden on healthcare systems worldwide.
Grant CPP2024-011368 funded by MCIN/AEI/10.13039/501100011033 and by FEDER, UE
